Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors

Vincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk-Jarzynka, Hanna Julie Hoel, Weiwen Yang, Daniel Palacios, Hilde Almåsbak, Malgorzata Bajor, Dennis Clement, Ludwig Brandt, Björn Önfelt, Jodie Goodridge, Magdalena Winiarska, Radoslaw Zagozdzon, Johanna Olweus, Jon-Amund Kyte and Karl-Johan Malmberg
Vincent Yi Sheng Oei
1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
2The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Siernicka
3Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
4Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agnieszka Graczyk-Jarzynka
3Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanna Julie Hoel
1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weiwen Yang
1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Palacios
1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
2The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hilde Almåsbak
1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malgorzata Bajor
3Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis Clement
1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
2The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ludwig Brandt
5Science for Life Laboratory, Department of Applied Physics, KTH–Royal Institute of Technology, Solna, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Björn Önfelt
5Science for Life Laboratory, Department of Applied Physics, KTH–Royal Institute of Technology, Solna, Sweden.
6Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jodie Goodridge
1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
2The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magdalena Winiarska
3Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Radoslaw Zagozdzon
3Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
7Department of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, Warsaw, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanna Olweus
1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
2The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon-Amund Kyte
1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
8Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl-Johan Malmberg
1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
2The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
9Centre for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: k.j.malmberg@medisin.uio.no
DOI: 10.1158/2326-6066.CIR-17-0207 Published April 2018
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2018 to January 2021

AbstractFull-text HTMLPDF
Total169452272931

Cited By

Article Information

Volume 6, Issue 4, pp. 467-480

DOI 
https://doi.org/10.1158/2326-6066.CIR-17-0207
PubMed 
29459477

Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074
History 
  • Received April 19, 2017
  • Revision received November 13, 2017
  • Accepted February 1, 2018
  • Published first February 19, 2018.

Article Versions

  • Previous version (February 19, 2018 - 09:52).
  • Previous version (March 12, 2018 - 07:37).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2018 American Association for Cancer Research.

Author Information

  1. Vincent Yi Sheng Oei1,2,
  2. Marta Siernicka3,4,
  3. Agnieszka Graczyk-Jarzynka3,
  4. Hanna Julie Hoel1,
  5. Weiwen Yang1,
  6. Daniel Palacios1,2,
  7. Hilde Almåsbak1,
  8. Malgorzata Bajor3,
  9. Dennis Clement1,2,
  10. Ludwig Brandt5,
  11. Björn Önfelt5,6,
  12. Jodie Goodridge1,2,
  13. Magdalena Winiarska3,
  14. Radoslaw Zagozdzon3,7,
  15. Johanna Olweus1,2,
  16. Jon-Amund Kyte1,8, and
  17. Karl-Johan Malmberg1,2,9,*
  1. 1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
  2. 2The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  3. 3Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
  4. 4Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.
  5. 5Science for Life Laboratory, Department of Applied Physics, KTH–Royal Institute of Technology, Solna, Sweden.
  6. 6Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  7. 7Department of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, Warsaw, Poland.
  8. 8Department of Oncology, Oslo University Hospital, Oslo, Norway.
  9. 9Centre for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  1. ↵*Corresponding Author:
    Karl-Johan Malmberg, Oslo University Hospital, Ullernchausseen 70, 0310 OSLO, Phone: 47-45390926; E-mail: k.j.malmberg{at}medisin.uio.no
View Full Text
PreviousNext
Back to top
Cancer Immunology Research: 6 (4)
April 2018
Volume 6, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
Vincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk-Jarzynka, Hanna Julie Hoel, Weiwen Yang, Daniel Palacios, Hilde Almåsbak, Malgorzata Bajor, Dennis Clement, Ludwig Brandt, Björn Önfelt, Jodie Goodridge, Magdalena Winiarska, Radoslaw Zagozdzon, Johanna Olweus, Jon-Amund Kyte and Karl-Johan Malmberg
Cancer Immunol Res April 1 2018 (6) (4) 467-480; DOI: 10.1158/2326-6066.CIR-17-0207

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
Vincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk-Jarzynka, Hanna Julie Hoel, Weiwen Yang, Daniel Palacios, Hilde Almåsbak, Malgorzata Bajor, Dennis Clement, Ludwig Brandt, Björn Önfelt, Jodie Goodridge, Magdalena Winiarska, Radoslaw Zagozdzon, Johanna Olweus, Jon-Amund Kyte and Karl-Johan Malmberg
Cancer Immunol Res April 1 2018 (6) (4) 467-480; DOI: 10.1158/2326-6066.CIR-17-0207
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Activin A Mediates Radiation-Induced Antitumor Immunity
  • Mechanisms to CD3-Bispecific Antibody Therapy
  • Improved Estimation of T-cell Receptor Repertoire Diversity
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement